Assessment of Alcohol Consumption in Liver Transplant Candidates and Recipients: The Best Combination of the Tools Available
|
|
- Ethel Lewis
- 5 years ago
- Views:
Transcription
1 LIVER TRANSPLANTATION 20: , 2014 ORIGINAL ARTICLE Assessment of Alcohol Consumption in Liver Transplant Candidates and Recipients: The Best Combination of the Tools Available Salvatore Piano, 1 Lucio Marchioro, 1 Elisabetta Gola, 1 Silvia Rosi, 1 Filippo Morando, 1 Marta Cavallin, 1 Antonietta Sticca, 1 Silvano Fasolato, 1 Giovanni Forza, 2 Anna Chiara Frigo, 3 Mario Plebani, 1 Giacomo Zanus, 4 Umberto Cillo, 4 Angelo Gatta, 1 and Paolo Angeli 1,5 1 Department of Medicine, 2 Forensic Toxicology Unit, Department of Molecular Medicine, 3 Department of Cardiologic, Thoracic, and Vascular Sciences, 4 Unit of Hepatobiliary Surgery and Liver Transplantation, and 5 Unit of Hepatic Emergencies and Liver Transplantation, University of Padua, Padua, Italy The detection of alcohol consumption in liver transplant candidates (LTCs) and liver transplant recipients (LTRs) is required to enable a proper assessment of transplant eligibility and early management of alcohol relapse, respectively. In this clinical setting, urinary ethyl glucuronide (uetg), the Alcohol Use Disorders Identification Test for Alcohol Consumption (AUDIT-c), serum ethanol, urinary ethanol, carbohydrate-deficient transferrin (CDT), and other indirect markers of alcohol consumption were evaluated and compared prospectively in 121 LTCs and LTRs. Alcohol consumption was diagnosed when AUDIT-c results were positive or it was confirmed by a patient s history in response to abnormal results. Alcohol consumption was found in 30.6% of the patients. uetg was found to be the strongest marker of alcohol consumption (odds ratio , P < 0.001) and provided a more accurate prediction rate of alcohol consumption [area under receiving operating characteristic (ROC) curve ] than CDT (area under ROC curve , P < 0.001) and AUDIT-c (area under ROC curve , P < 0.001). The combination of uetg and AUDIT-c showed higher accuracy in detecting alcohol consumption in comparison with the combination of CDT and AUDIT-c (area under ROC curve versus 0.80, P < 0.001). Furthermore, uetg was the most useful marker for detecting alcohol consumption in patients with negative AUDIT-c results. In conclusion, the combination of AUDIT-c and uetg improves the detection of alcohol consumption in LTCs and LTRs. Therefore, they should be used routinely for these patients. Liver Transpl 20: , VC 2014 AASLD. Received December 16, 2013; accepted March 26, Alcoholic liver disease is one of the most common indications for liver transplantation (LT) in both Europe and the United States. 1,2 Alcohol relapse after LT has been reported in 11% to 49% of patients, 3-5 and it is associated with graft dysfunction and a worse survival rate in comparison with abstinent patients. 6-8 Therefore, an assessment of drinking status is crucial to the selection of liver transplant candidates (LTCs). Most transplant centers in the United States require a 6-month period of abstinence before a patient is considered eligible for LT because it has been shown to predict a low rate of relapse into drinking after LT. 9,10 Abbreviations: q, correlation coefficient; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUDIT, Alcohol Use Disorders Identification Test; AUDIT-c, Alcohol Use Disorders Identification Test for Alcohol Consumption; CDT, carbohydratedeficient transferrin; CI, confidence interval; EtG, ethyl glucuronide; GGT, gamma-glutamyl transpeptidase; LT, liver transplantation; LTC, liver transplant candidate; LTR, liver transplant recipient; MCV, mean corpuscular volume; NPV, negative predictive value; NS, not significant; OR, odds ratio; PPV, positive predictive value; ROC, receiving operating characteristic; setoh, serum ethanol; TLFB, Timeline Followback; uetg, urinary ethyl glucuronide; uetoh, urinary ethanol; NAD, oxidazed nicotinamide adenine dinucleotide; NADH, reduced nicotinamide adenine dinucleotide. No grants supported this study. The authors of this article have no conflicts of interest to disclose as described by Liver Transplantation. Address reprint requests to Paolo Angeli, M.D., Ph.D., Department of Medicine, University of Padua, Via Giustiniani 2, Padua, Italy. Telephone: 0039/ ; FAX: 0039/ ; pangeli@unipd.it DOI /lt View this article online at wileyonlinelibrary.com. LIVER TRANSPLANTATION.DOI /lt. Published on behalf of the American Association for the Study of Liver Diseases VC 2014 American Association for the Study of Liver Diseases.
2 816 PIANO ET AL. LIVER TRANSPLANTATION, July 2014 However, after a patient is considered eligible for LT by a health care professional experienced in the management of patients with addictive behavior, the transplant hepatologist needs to check the drinking status. Verbal reports by LTCs may underestimate their actual drinking habits, particularly if they believe that it may delay or prevent LT. Consequently, a valid screening tool is needed for the assessment of drinking status during the pretransplant period. In the general population, markers of damage such as gamma-glutamyl transpeptidase (GGT), the aminotransferase (AST)/alanine aminotransferase (ALT) ratio, and the mean corpuscular volume (MCV) have been shown to be useful in detecting alcohol consumption. 11,12 However, in patients with liver disease and/or liver transplant recipients (LTRs), their accuracy decreases. 13 Carbohydrate-deficient transferrin (CDT) is another marker of alcohol consumption that can be used to identify continuous, excessive drinking (50-80 g of ethanol/day) over a period of at least 1 week. 14 A limitation of CDT is that it is unable to identify lower alcohol consumption, and its accuracy is limited in patients with liver cirrhosis. 4 This reduced accuracy is due at least in part to methodological factors. A conventional immunoassay may produce several false-positive results because liver disease and perhaps other factors such as di-tri bridging can lead to falsely elevated results. 15 As a result, it has been stated that CDT should be measured with highperformance liquid chromatography, particularly in patients with chronic liver disease. 15 Other direct markers of alcohol consumption such as serum ethanol (setoh) and urinary ethanol (uetoh) can be used to identify small amounts of alcohol, but their application is limited by the time of detection, which ranges from 8 hours for setoh to 24 hours for uetoh. 16 Recently, urinary ethyl glucuronide (uetg) has been shown to be a reliable screening tool for the detection of alcohol consumption in LTCs and LTRs. 13,17 uetg is detectable after the consumption of very small amounts of ethanol (<10 g), and it can be found in the urine for up to 80 hours after the last drink. 18 Ethyl glucuronide (EtG) can be measured by liquid chromatography mass spectroscopy and liquid chromatography tandem mass spectroscopy. A faster and less costly method involving an immunoassay has been developed and validated. 19 Recently, data have shown that uetg is capable of improving the detection of alcohol consumption in LTCs and LTRs. 13 Furthermore, the determination of EtG in hair has been shown to improve the evaluation of long-term alcohol abstinence in LTCs. 20 As for the self-reporting of alcohol consumption, it is well known that verbal reports of drinking behavior by LTCs may underestimate their actual drinking. Consequently, it is important to use a validated screening test for the detection of alcohol consumption. To date, only the Timeline Followback (TLFB) test has been used for LTCs and LTRs. 21 The Alcohol Use Disorders Identification Test for Alcohol Consumption (AUDIT-c) represents a simple and reliable test for the detection of alcohol consumption and hazardous drinking 22 and has been proposed by the World Health Organization for the assessment of hazardous drinking in primary care. 23 The Italian version has also been validated. 24 Nevertheless, it has never been applied to LTCs and LTRs. The aim of our study was to evaluate the accuracy of AUDIT-c, CDT, uetg, setoh, uetoh, and other indirect markers in the detection of alcohol consumption in LTCs and LTRs and thereby assess the best screening tools for these patients. PATIENTS AND METHODS Patient Population From January 2011 to December 2012, 121 patients LTCs affected by alcoholic cirrhosis and LTRs with alcoholic cirrhosis before LT were consecutively enrolled and prospectively evaluated as outpatients in the care management program of our unit. 25 The diagnosis of cirrhosis was based on histological findings (when available) or a combination of clinical, biochemical, ultrasonographic, and endoscopic findings. The study was approved by the ethics committee of the University of Padua and the General Hospital of Padua (protocol identification number 2068P). Written informed consent was obtained from each patient. Methods In the pretransplant setting, patients were checked with an individualized frequency ranging from every week to every month according to the severity of their liver disease. In the posttransplant setting, the frequency of scheduled visits was dependent on the time since LT and/or the development of complications. Accordingly, LTRs without complications were checked every month during the first 6 months after LT, every 2 to 3 months during 6-12 months after LT, and every 3 to 6 months thereafter. A relapse into drinking by LTRs was considered to be a medical complication. LTRs with a medical complication were checked more closely according to the type, severity, and evolution of the complication. The individualized frequencies of visits for these LTRs ranged from every week to every month. For the purpose of this study, patients were interviewed during each visit by a hepatologist with respect to recent alcohol consumption; AUDIT-c was administered by the physician, and the score was calculated on the basis of responses to the following 3 questions with all types of alcohol combined: (1) the overall frequency of drinking, (2) the usual quantity of drinks consumed, and (3) the frequency of the consumption of 5 or more drinks. AUDIT-c was preferred to other tools such as the full Alcohol Use Disorders Identification Test (AUDIT) and TLFB because its compilation is simpler and less time consuming and it is, therefore, more suitable for assessing outpatients. AUDIT-c focuses on alcohol consumption (frequency and
3 LIVER TRANSPLANTATION, Vol. 20, No. 7, 2014 PIANO ET AL. 817 amount of drinking and episodes of heavy drinking) rather than alcohol dependence and has been found to be as accurate as the full AUDIT for detecting heavy drinking and/or active abuse or dependence in the general population. 22 During each visit, blood and urine samples were collected for the detection of all alcohol markers. Urine samples were taken under the supervision of a nurse waiting in front of the bathroom door. When alcohol consumption was detected via any of the alcohol markers and the patient denied alcohol consumption according to AUDIT-c, he or she was scheduled for another visit and confronted with the test results. LTCs and LTRs who reported alcohol consumption were referred to our alcohol addiction unit for further evaluation and treatment. For LTCs, a reassessment of their eligibility was performed on a case-by-case basis by an addictive behavior specialist. Analytical Methods The determination of EtG was performed with a homogeneous immunoenzymatic assay. The DRI EtG enzyme immunoassay (Microgenics Corp., Fremont, CA) is based on the competition between a drug labeled with glucose-6-phosphate dehydrogenase and free drug contained in the urine sample for a fixed numbered of specific antibody binding sites. Antigenantibody binding modulates the enzymatic activity: in the absence of free drug in the urine specimen, the specific antibody binds the drug labeled with glycerol- 3-phosphate dehydrogenase and causes a reduction in enzymatic activity. This phenomenon favors a direct relationship between the urinal drug concentration and the enzymatic activity. At a wavelength of 540 nm, the active enzyme converts oxidized nicotinamide adenine dinucleotide (NAD) into reduced nicotinamide adenine dinucleotide (NADH) with a consequent increase in absorbance that can be measured spectrophotometrically. The EtG assay was applied with the Cobas 6000 automatic analyzer (version c501, Roche Diagnostics). The determination of uetg was performed on the day of the sample collection. A value > 500 ng/ml was considered positive. 19 The determination of ethyl alcohol in urine and plasma specimens was made with an enzymatic method (ETOH2, Roche Diagnostics). Alcohol dehydrogenase converts ethanol into acetaldehyde and reduces NAD 1 into NADH plus H 1. The NADH that is formed during the reaction (measured spectrophotometrically at 340 nm) is directly proportional to the ethanol concentration in a sample. The method was the same for both biological matrices, and it was applied with the same instrument used for the EtG assay. The percentage quantification of CDT was carried out with an Agilent 1100 series high-performance liquid chromatography system with an ultraviolet detector (Agilent Technologies, United States). The separation of transferrin glycoforms was performed with an anionexchange chromatography column (Bio-Rad Laboratories, Germany). A value higher than 2.1% was considered positive according to the manufacturer. AST (cutoff < 45 U/L for men and < 35 U/L for women), ALT (cutoff < 50 U/L for men and < 35 U/L for women), GGT (cutoff < 65 U/L for men and < 45 U/L for women), and MCV (cutoff < 96 fl) were also assessed at each visit. The AST/ALT ratio was calculated. Values 2 were considered to be indicative of advanced alcoholic liver disease. 12 In order to identify any intentional dilution of urine samples, the urinary creatinine level was determined with the Jaffe reaction method. Definition of Alcohol Consumption The detection of alcohol consumption was based on patient self-report (AUDIT-c) or the acknowledgment by a patient who had previously denied it via AUDIT-c after he or she was informed of abnormal results for 1 or more markers of alcohol consumption (setoh, uetoh, uetg, and CDT). Statistical Analysis A statistical analysis was conducted with SAS 9.2 for Windows (SAS Institute, Inc., Cary, NC). Quantitative variables are reported as means and standard deviations. Categorical variables are reported as counts and percentages in each category. On the basis of patients self-reports after confrontation with their results, the sensitivity, specificity, positive predictive values (PPVs), negative predictive values (NPVs), positive likelihood ratios, negative likelihood ratios, and accuracy of the tests were calculated. Markers predicting alcohol consumption were identified separately with a logistic regression analysis for each predictor. Subsequently, all predictors that had a P value < 0.1 were included in a multivariate logistic regression analysis. Results are presented as P values with odds ratios (ORs) and 95% confidence intervals (CIs). Spearman s rank correlation was used to detect the correlation between alcohol markers and the amount of alcohol consumption. The comparison of markers of alcohol consumption in the detection of alcohol consumption was performed with the C statistic and the area under the receiving operating characteristic (ROC) curve. RESULTS Characteristics of Patients Baseline demographic, clinical, and laboratory data for the patients included in this study are reported in Table 1. The mean age of the patients was years, and 94 (77.7%) were male. Hepatitis B virus and hepatitis C virus were detected in 6 (5%) and 23 patients (19%), respectively. Ninety-eight patients (81%) were LTCs, whereas 23 (19%) were LTRs. The mean age of the LTCs was 55.7 years, and 76 (77.6%) were male. The indications for LT in the LTCs were decompensated liver cirrhosis (n 5 77) and hepatocellular carcinoma (n 5 21). As for the LTRs, the mean age was 60.0 years old, and 18 (78.3%) were male. The indications for LT in the LTRs were decompensated
4 818 PIANO ET AL. LIVER TRANSPLANTATION, July 2014 TABLE 1. Demographic and Clinical Characteristics of the Patients Whole Population (n 5 121) LTCs (n 5 98) LTRs (n 5 23) Age (years)* Sex [n (%)] Male 94 (77.7) 76 (77.6) 18 (78.3) Female 27 (22.3) 22 (22.4) 5 (21.7) Ethnicity (n) Caucasian Black Asian Associated viral etiology 29 (24) 22 (22.4) 7 (30.4) of liver disease [n (%)] Alcohol-dependent patients [n (%)] 39 (32.2) 33 (33.7) 6 (26.1) Alcohol abusers [n (%)] 82 (67.8) 65 (66.3) 17 (73.9) Alcohol consumption [n (%)] Yes 37 (30.6) 32 (32.7) 5 (21.7) No 84 (69.4) 66 (67.3) 18 (78.3) Alcohol consumption of drinkers (drinks/week)* *The data are presented as means and standard deviations. According to Diagnostic and Statistical Manual of Mental Disorders IV criteria. Reported by patients. TABLE 2. Correlation Between Alcohol Markers and the Amount of Alcohol Consumption q P Value AUDIT-c 0.43 <0.001 uetg 0.53 <0.001 CDT 0.35 <0.01 GGT (U/L) 0.35 <0.001 AST/ALT ratio 0.13 NS MCV (fl) 0.11 NS liver cirrhosis (n 5 13), hepatorenal syndrome (n 5 3), and hepatocellular carcinoma (n 5 7). Detection of Alcohol Consumption Alcohol consumption was detected in 37 of the 121 patients (30.6%). Alcohol use was found in 5 of the 23 LTRs (21.7%) and in 32 of the 98 LTCs (32.7%). Seventeen (14%) reported alcohol consumption according to AUDIT-c. Twenty patients (16.5%) who denied any alcohol intake on AUDIT-c then reported alcohol consumption when they were confronted with abnormal results for at least 1 marker. Nineteen of these 20 patients (95%) were found to be positive for uetg, and 5 (25%) were found to be positive for CDT (P < ). Only 1 of the 5 patients who were positive for CDT was negative for uetg. Correlation Between Alcohol Markers and Amount of Alcohol Consumption Patients whose alcohol consumption was detected reported a mean consumption of drinks per week. We found a statistically significant correlation between the amount of weekly alcohol intake and uetg [correlation coefficient (q) , P < 0.001], AUDIT-c (q , P < 0.001), CDT (q , P < 0.01), and GGT (q , P < 0.001; Table 2). No correlation was found between the amount of weekly alcohol intake and the AST/ALT ratio or MCV. Comparison of Alcohol Markers in the Detection of Alcohol Consumption In Table 3, we report the sensitivity, specificity, PPVs, NPVs, positive likelihood ratios, negative likelihood ratios, and accuracy of alcohol markers. uetg showed the highest sensitivity (89.2%; 95% CI %-99.2%) and accuracy (95.9%; 95% CI %-99.5%) in comparison with the other alcohol markers. Only 1 of the 34 patients who were found to be positive for uetg denied alcohol consumption when she was confronted with her results. CDT performed better for LTRs (sensitivity 5 60%, specificity 5 100%, PPV 5 100%, NPV 5 90%, accuracy %) versus LTCs (sensitivity 5 25%, specificity %, PPV %, NPV , accuracy %). It is worth noting that for 9 LTCs, the correct quantification of CDT was not possible because they showed poor chromatographic resolution of disialotransferrin from trisialotransferrin (a phenomenon known as di-tri bridging). 15 Among these LTCs, 3 were found to be actively consuming alcohol. In the univariate analysis, AUDIT-c (OR ; 95% CI to >999.99), uetg (OR ; 95% CI to >999.99), CDT (OR ; 95% CI ), and GGT (OR ; 95% CI ) were found to be predictors of alcohol consumption (Table 4). In the multivariate analysis,
5 LIVER TRANSPLANTATION, Vol. 20, No. 7, 2014 PIANO ET AL. 819 TABLE 3. Comparison of Markers of Alcohol Abuse in the Detection of Alcohol Consumption Negative Likelihood Ratio Accuracy (%) Positive Marker Sensitivity (%) Specificity (%) PPV (%) NPV (%) Likelihood Ratio uetg 89.2 ( ) 98.8 ( ) 97.1 ( ) 95.4 ( ) ( ) 0.11 ( ) 95.9 ( ) AUDIT-c 45.9 ( ) 100 ( ) 100 ( ) 80.8 ( ) 0.54 ( ) 83.5 ( ) CDT 29.7 ( ) 96.4 ( ) 78.6 ( ) 75.5 ( ) 8.23 ( ) 0.73 ( ) 75.8 ( ) uetoh 10.8 ( ) 100 ( ) 100 ( ) 71.8 ( ) 0.89 ( ) 69.4 ( ) setoh 10.8 ( ) 100 ( ) 100 ( ) 71.8 ( ) 0.89 ( ) 69.4 ( ) AST/ALT ratio > ( ) 81 ( ) 40.7 ( ) 72.3 ( ) 1.56 ( ) 0.87 ( ) 65.3 ( ) GGT (U/L) 73.0 ( ) 66.7 ( ) 49.1 ( ) 84.9 ( ) 2.19 ( ) 0.41 ( ) 68.6 ( ) MCV (fl) 37.8 ( ) 77.4 ( ) 42.4 ( ) 73.9 ( ) 1.67 ( ) 0.80 ( ) 65.3 ( ) NOTE: Ninety-five percent CIs are presented in parentheses. AUDIT-c (OR ; 95% CI to >999.99) and uetg (OR ; 95% CI to >999.99) were found to be the only independent predictors of alcohol consumption (Table 5). Subsequently, the accuracies of alcohol markers (uetg, AUDIT-c, and CDT) were compared. uetg (C statistic ; 95% CI ) was more accurate than AUDIT-c (C statistic ; 95% CI , P < 0.001), CDT (C statistic ; 95% CI , P < 0.001), and the combination of AUDIT-c and CDT (C statistic ; 95% CI , P ; Tables 6 and 7). Furthermore, the combination of AUDIT-c and uetg (C statistic ; 95% CI ) was found to slightly improve the accuracy of uetg (P ; Table 7) and to be the most accurate combination of alcohol markers. The addition of CDT to AUDIT-c and uetg was unable to further improve the model. DISCUSSION Although the length of abstinence from alcohol consumption is a matter of debate for patients who are potentially candidates for LT, there is no doubt that abstinence is required in the selection process for LT in patients with alcohol-related cirrhosis. 26 A period of abstinence before LT is one of the criteria necessary to limit relapse into alcohol consumption after LT. There is no doubt that a small proportion of patients undergoing transplantation (LTRs) return to damaging drinking behavior. This can result in graft loss or patient death because of noncompliance with immunosuppressive therapy and/or direct hepatotoxic effects of alcohol on the graft. 6-8 Therefore, the monitoring of abstinence from alcohol consumption is a critical step in the management of LTCs and LTRs. The results of our study show that uetg is the most accurate marker of alcohol consumption in this clinical setting. In our study, uetg was capable of improving the detection of alcohol consumption in comparison with all other conventionally used markers and patient self-reporting. The enhanced accuracy of uetg in comparison with indirect markers in the detection of alcohol consumption has already been previously reported 13,17 ; therefore, the results of this study were almost to be expected. On the other hand, the higher accuracy of uetg versus AUDIT-c and CDT the most original result of this study deserves some comment. As far as AUDIT-c is concerned, it should be highlighted that it has not been previously reported for the detection of alcohol consumption in LTCs and LTRs. AUDIT-c was preferred to other tools such as TLFB for collecting self-reported drinking information because its compilation is simpler and less time-consuming and it is, therefore, more suitable for assessing outpatients. AUDIT-c was found to be an independent predictor of alcohol consumption and, despite its low sensitivity, was capable of detecting alcohol consumption in 3 patients who were found to have normal values for all other markers of alcohol consumption. The accuracy of
6 820 PIANO ET AL. LIVER TRANSPLANTATION, July 2014 TABLE 4. Prediction of Alcohol Consumption With Alcohol Markers According to the Univariate Analysis TABLE 6. Diagnostic Accuracy of Markers of Alcohol Consumption OR 95% CI P Value AUDIT-c to <0.001 > uetg to <0.001 > CDT <0.001 GGT (U/L) <0.001 AST/ALT ratio NS MCV (fl) NS C Statistic 95% CI AUDIT-c uetg CDT AUDIT-c 1 CDT AUDIT-c 1 uetg AUDIT-c 1 CDT 1 uetg TABLE 5. Risk Estimation of Alcohol Consumption With Alcohol Markers According to the Multivariate Analysis OR 95% CI P Value AUDIT-c to > uetg to > <0.001 AUDIT-c for the detection of alcohol consumption in our cohort of patients was lower than that reported in previous studies for the general population. 21 This result is not surprising because it is well known that LTCs and LTRs are used to denying alcohol consumption, especially when verbal self-reporting is adopted. 13 This is particularly true for LTCs, who know that an admission of alcohol consumption can prevent or at least delay their eligibility for LT. 26 As for CDT, another relevant result of the study shows that it is not an independent predictor of alcohol consumption in LTCs and LTRs (Table 4). Only in 5 of 20 patients who had denied alcohol consumption on AUDIT-c did an abnormal increase in CDT contribute to the detection of alcohol consumption by the patient, and in only 1 patient (an LTR) was it not associated with an abnormal value of uetg. In good agreement with previous studies, 27,28 CDT showed lower accuracy in LTCs versus LTRs in our study. This is not surprising because CDT loses its accuracy in patients with liver diseases and particularly in patients with liver cirrhosis. 4,27,29 The low accuracy of CDT in patients with cirrhosis is related first to a methodological factor. It has been suggested that an elevated value of CDT, detected by means of a conventional immunoassay, does not accurately predict alcohol consumption in patients with advanced liver disease because the immunoassay detects several false-positive results. The false-positive results are related to the fact that liver disease and perhaps other factors such as di-tri bridging can lead to falsely elevated results. 15 Although the molecular basis for this effect is not known, the relationship between di-tri bridging and chronic liver disease is so strong that it points to di-tri bridging being suggestive of liver disease. 15 As a result, it has been stated that CDT should be measured with high-performance liquid chromatography, particularly in patients with chronic liver disease. 15 In fact, high-performance liquid chromatography can avoid the negative effects of liver abnormalities on the chromatographic separation of transferrin glycoforms by minimizing the reporting of false positives but without providing for them a valid detection of alcohol consumption. In our study, the use of high-performance liquid chromatography was not able to improve the accuracy of CDT in patients with chronic liver disease. In good agreement with these observations, the accuracy of CDT was low for the entire series of patients in our study. CDT seemed to recover accuracy to some extent when we moved from LTCs to LTRs, although the small number of LTRs in our study did not allow reliable conclusions regarding the accuracy of CDT in these patients. The first strong point in favor of the use of uetg for monitoring abstinence is that its value is not affected at all by liver disease. Clinical studies have shown that uetg has similar accuracy in patients with advanced liver disease versus the general population. 18,30 The low accuracy of CDT was also related to the particular condition of the patients who were included in our study. These patients were closely followed because either they were in the selection process for LT or on the waiting list for LT or they had already undergone LT. It can be easily assumed that for LTCs, not only the fear of causing further liver damage but also the fear of being excluded from the transplant waiting list may have limited the extent of alcohol consumption. Similarly, in the LTRs, the complexity of the procedure to which they had been subjected and the fear of breaking a moral deal with the transplant team may have produced the same effect. What is certain is that the alcohol consumption reported by our patients is far from that required to achieve a CDT value higher than 2.1%. Therefore, the second strong point in favor of the use of uetg for monitoring abstinence in LTCs and LTRs is its higher sensitivity in comparison with CDT for these patterns of alcohol consumption. The consumption of even small amounts of ethanol (10 g) can result in
7 LIVER TRANSPLANTATION, Vol. 20, No. 7, 2014 PIANO ET AL. 821 TABLE 7. Comparison of the Diagnostic Accuracy of Markers of Alcohol Consumption ROC Contrast Estimate 95% CI P Value uetg versus <0.001 AUDIT-c uetg versus CDT <0.001 uetg versus AUDIT-c 1 CDT AUDIT-c 1 uetg versus uetg to 0.09 AUDIT-c 1 uetg <0.001 versus CDT 1 uetg AUDIT-c 1 CDT 1 uetg versus AUDIT-c 1 uetg to 0.01 NS NOTE: The comparison of markers of alcohol consumption was performed with ROC contrast estimation. positive uetg findings for up to 80 hours after the last drink. 18 As for the last point, it is important to consider that the detection of a small amount of alcohol consumption can have different impacts on the management of LTCs and LTRs. In patients with cirrhosis, even a small amount of alcohol is able to significantly increase the portal pressure, 31 and it can increase the risk of gastrointestinal bleeding and other complications. As a result, the prompt identification and treatment of active drinkers is mandatory. In this setting, because of its high sensitivity, uetg represents a useful tool for detecting active drinkers and thereby allowing their prompt referral to intensive and multidisciplinary management, as mentioned previously. In LTRs, different patterns of alcohol consumption have been shown. 32 In clinical practice, it is important to differentiate between slips (the resumption of drinking small amounts) and relapse (a return to addictive drinking). Among LTRs, the resumption of addictive drinking is associated with injury to the graft and mortality. 6-8 In this setting, an isolated uetg-positive result can reveal a slip. Although slips are not necessarily associated with graft dysfunction, 33 they may be the harbinger of a relapse. Consequently, it is very important to identify slips in order to enable the patient to get help and, therefore, prevent a relapse. The last point in favor of uetg versus CDT is related to the fact that uetg in our country is somewhat cheaper (approximately $7/test) than CDT (approximately $30/test). We realize that costs may vary widely across countries; nevertheless, at least the cost of CDT is the same as that in the United States. 34 Our study has some limitations. First of all, we used an enzyme immunoassay for the measurement of uetg, and the results were not confirmed with liquid chromatography mass spectroscopy or liquid chromatography tandem mass spectroscopy. Nevertheless, the DRI EtG enzyme immunoassay has been validated in different studies. 13,19 Moreover, it is worth noting that the ethanol contained in mouthwash solutions, alcohol-based hand sanitizers, and the ingestion of baker s yeast can lead to false-positive results, 35,36 although the level of uetg is usually expected to remain below the cutoff of 500 ng/ml. However, these possibilities should always be taken into account when one is interpreting test results, and they are the reason that a patient was considered to be a true positive for alcohol consumption only after his or her own admission. As for this last point, we would like to emphasize that the assessment of alcohol consumption with the use of biomarkers goes in parallel with the promotion of mutual trust between physicians and patients. 37 In conclusion, the combination of AUDIT-c and uetg substantially improves the detection of alcohol consumption in these patients. We suggest using uetg and AUDIT-c at each visit for LTCs and randomly for LTRs. 38 However, uetg and AUDIT-c should be used at each visit even for LTRs whenever clinical suspicion or risk factors 39 for relapse into drinking occur. REFERENCES 1. Burra P, Senzolo M, Adam R, Delvart V, Karam V, Germani G, Neuberger J; for ELITA and ELTR Liver Transplant Centers. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant 2010; 10: Futagawa Y, Terasaki PI. An analysis of the OPTN/UNOS liver transplant registry. Clin Transpl 2004: Mackie J, Groves K, Hoyle A, Garcia C, Garcia R, Gunson B, Neuberger J. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transpl 2001;7: Berlakovich GA, Soliman T, Freundorfer E, Windhager T, Bodingbauer M, Wamser P, et al. Pretransplant screening of sobriety with carbohydrate-deficient transferrin in patients suffering from alcoholic cirrhosis. Transpl Int 2004;17: Tandon P, Goodman KJ, Ma MM, Wong WW, Mason AL, Meeberg G, et al. A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation. Am J Gastroenterol 2009;104: Cuadrado A, Fabrega E, Casafont F, Pons-Romero F. Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2005;11: Faure S, Herrero A, Jung B, Duny Y, Daures JP, Mura T, et al. Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication. J Hepatol 2012;57: Rice JP, Eickhoff J, Agni R, Ghufran A, Brahmbhatt R, Lucey MR. Abusive drinking after liver transplantation is associated with allograft loss and advanced allograft fibrosis. Liver Transpl 2013;19: O Shea RS, Dasarathy S, McCullough AJ; for Practice Guideline Committee of the American Association for the
8 822 PIANO ET AL. LIVER TRANSPLANTATION, July 2014 Study of Liver Diseases and Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology 2010;51: Osorio RW, Ascher NL, Avery M, Bacchetti P, Roberts JP, Lake JR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 1994;20(pt 1): Hietala J, Puukka K, Koivisto H, Anttila P, Niemel a O. Serum gamma-glutamyl transferase in alcoholics, moderate drinkers and abstainers: effect on gt reference intervals at population level. Alcohol Alcohol 2005;40: Nyblom H, Berggren U, Balldin J, Olsson R. High AST/ ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol 2004;39: Staufer K, Andresen H, Vettorazzi E, Tobias N, Nashan B, Sterneck M. Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Hepatology 2011;54: Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991;37: Stewart SH, Comte-Walters S, Bowen E, Anton RF. Liver disease and HPLC quantification of disialotransferrin for heavy alcohol use: a case series. Alcohol Clin Exp Res 2010;34: Helander A, Eriksson CJ; for WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence Investigators. Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence. Alcohol Clin Exp Res 2002;26: Erim Y, B ottcher M, Dahmen U, Beck O, Broelsch CE, Helander A. Urinary ethyl glucuronide testing detects alcohol consumption in alcoholic liver disease patients awaiting liver transplantation. Liver Transpl 2007;13: Wurst FM, Wiesbeck GA, Metzger JW, Weinmann W. On sensitivity, specificity, and the influence of various parameters on ethyl glucuronide levels in urine results from the WHO/ISBRA study. Alcohol Clin Exp Res 2004; 28: B ottcher M, Beck O, Helander A. Evaluation of a new immunoassay for urinary ethyl glucuronide testing. Alcohol Alcohol 2008;43: Sterneck M, Yegles M, von Rothkirch G, Staufer K, Vettorazzi E, Schulz KH, et al. Determination of ethyl glucuronide in hair improves evaluation of long-term alcohol abstention in liver transplant candidates. Liver Int 2014;34: DiMartini A, Day N, Dew MA, Lane T, Fitzgerald MG, Magill J, Jain A. Alcohol use following liver transplantation: a comparison of follow-up methods. Psychosomatics 2001;42: Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT- C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998;158: Johnson JA, Lee A, Vinson D, Seale JP. Use of AUDITbased measures to identify unhealthy alcohol use and alcohol dependence in primary care: a validation study. Alcohol Clin Exp Res 2013;37(suppl 1):E253-E Piccinelli M, Tessari E, Bortolomasi M, Piasere O, Semenzin M, Garzotto N, Tansella M. Efficacy of the Alcohol Use Disorders Identification Test as a screening tool for hazardous alcohol intake and related disorders in primary care: a validity study. BMJ 1997;314: Morando F, Maresio G, Piano S, Fasolato S, Cavallin M, Romano A, et al. How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol 2013;59: Allen JP, Wurst FM, Thon N, Litten RZ. Assessing the drinking status of liver transplant patients with alcoholic liver disease. Liver Transpl 2013;19: DiMartini A, Day N, Lane T, Beisler AT, Dew MA, Anton R. Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease. Alcohol Clin Exp Res 2001;25: Berlakovich GA, Windhager T, Freundorfer E, Lesch OM, Steininger R, M uhlbacher F. Carbohydrate deficient transferrin for detection of alcohol relapse after orthotopic liver transplantation for alcoholic cirrhosis. Transplantation 1999;67: Heinemann A, Sterneck M, Kuhlencordt R, Rogiers X, Schulz KH, Queen B, et al. Carbohydrate-deficient transferrin: diagnostic efficiency among patients with endstage liver disease before and after liver transplantation. Alcohol Clin Exp Res 1998;22: Stewart SH, Koch DG, Burgess DM, Willner IR, Reuben A. Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients. Alcohol Clin Exp Res 2013;37: Luca A, Garcıa-Pagan JC, Bosch J, Feu F, Caballerıa J, Groszmann RJ, Rodes J. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997;112: DiMartini A, Dew MA, Day N, Fitzgerald MG, Jones BL, devera ME, Fontes P. Trajectories of alcohol consumption following liver transplantation. Am J Transplant 2010;10: Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, N ussler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007;13: Dillie KS, Mundt M, French MT, Fleming MF. Cost-benefit analysis of a new alcohol biomarker, carbohydrate deficient transferrin, in a chronic illness primary care sample. Alcohol Clin Exp Res 2005;29: Arndt T, Gr uner J, Schr ofel S, Stemmerich K. False-positive ethyl glucuronide immunoassay screening caused by a propyl alcohol-based hand sanitizer. Forensic Sci Int 2012;223: Hïiseth G, Yttredal B, Karinen R, Gjerde H, Christophersen A. Levels of ethyl glucuronide and ethyl sulfate in oral fluid, blood, and urine after use of mouthwash and ingestion of nonalcoholic wine. J Anal Toxicol 2010; 34: Weinrieb RM, Van Horn DH, McLellan AT, Lucey MR. Interpreting the significance of drinking by alcoholdependent liver transplant patients: fostering candor is the key to recovery. Liver Transpl 2000;6: Dimartini AF, Dew MA. Monitoring alcohol use on the liver transplant wait list: therapeutic and practical issues. Liver Transpl 2012;18: Egawa H, Nishimura K, Teramukai S, Yamamoto M, Umeshita K, Furukawa H, Uemoto S. Risk factors for alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan. Liver Transpl 2014;20:
Relapse of alcohol consumption occurs in
Urinary Ethyl Glucuronide as a Novel Screening Tool in Patients Pre- and Post Liver Transplantation Improves Detection of Alcohol Consumption Katharina Staufer, 1 * Hilke Andresen, 2 * Eik Vettorazzi,
More informationAbusive Drinking After Liver Transplantation Is Associated With Allograft Loss and Advanced Allograft Fibrosis
LIVER TRANSPLANTATION 19:1377 1386, 2013 ORIGINAL ARTICLE Abusive Drinking After Liver Transplantation Is Associated With Allograft Loss and Advanced Allograft Fibrosis John P. Rice, 1 Jens Eickhoff, 2
More informationHigher levels of hair EtG in patients with decreased kidney function.
MD Jan Toralf Fosen 1, PhD Gudrun Høiseth 1, Ph.D Luca Morini 2, Prof. Jørg Mørland 1. 1 Norwegian Institute of Public Health, Division of forensic medicine and drug abuse research, Oslo, Norway. 2 Department
More informationMETHOD-DEPENDENT CHARACTERISTICS OF CARBOHYDRATE-DEFICIENT TRANSFERRIN MEASUREMENTS IN THE FOLLOW-UP OF ALCOHOLICS
Alcohol & Alcoholism Vol. 39, No. 1, pp. 59 63, 2004 doi:10.1093/alcalc/agh021, available online at www.alcalc.oupjournals.org METHOD-DEPENDENT CHARACTERISTICS OF CARBOHYDRATE-DEFICIENT TRANSFERRIN MEASUREMENTS
More informationRisk Factors, Scoring Systems, and Interventions for Alcohol Relapse After Liver Transplantation for Alcoholic Liver Disease
REVIEW Risk Factors, Scoring Systems, and Interventions for Alcohol Relapse After Liver Transplantation for Alcoholic Liver Disease Jane Lim, M.D.,* and Vinay Sundaram, M.D., M.Sc. Alcoholic liver disease
More information2/12/2019. Direct biomarkers of alcohol consumption in professionals health programs. Objectives. IPN/PRN Annual Conference and Evaluator Training
IPN/PRN Annual Conference and Evaluator Training Direct biomarkers of alcohol consumption in professionals health programs Scott A. Teitelbaum, M.D. Gary M. Reisfield, M.D. Division of Addiction Medicine
More informationAlcoholic Liver Disease as First Indication
Alcoholic Liver Disease as First Indication Patrizia Burra Multivisceral Transplant Unit Gastroenterology Department of Surgery, Oncology and Gastroenterology Padua University Hospital, Padua, Italy Patrizia
More informationLiver Transplant: Alcoholic liver disease as first indication
Monotematica AISF The future of liver disease: beyond HCV there is a role for hepatologist? Milano, 13-15 Ottobre 2016 Liver Transplant: Alcoholic liver disease as first indication Giacomo Germani Multivisceral
More informationMarkers of Alcohol Abuse in Alcoholic Liver Disease: sensitivity and specificity. Alessandro Federico University of Campania L.
Markers of Alcohol Abuse in Alcoholic Liver Disease: sensitivity and specificity Alessandro Federico University of Campania L. Vanvitelli Alessandro Federico Markers of Alcohol Abuse in Alcoholic Liver
More informationHair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 1
Hair ethylglucuronide and blood phosphatidylethanol detection of 4 DUI driver risk factors 1 Paul R. Marques 1 A. Scott Tippetts 1 Michel Yegles 2 1 Pacific Institute for Research and Evaluation 11720
More informationSubstance Use by Liver Transplant Candidates: An Anonymous Urinalysis Study
LIVER TRANSPLANTATION 17:1200 1204, 2011 ORIGINAL ARTICLE Substance Use by Liver Transplant Candidates: An Anonymous Urinalysis Study Ian Webzell, 1 David Ball, 3 James Bell, 3 Roy A. Sherwood, 2 Andrew
More informationDetecting Lifetime Alcohol Problems in Individuals Referred for Liver Transplantation for Nonalcoholic Liver Failure
LIVER TRANSPLANTATION 14:1609-1613, 2008 ORIGINAL ARTICLE Detecting Lifetime Alcohol Problems in Individuals Referred for Liver Transplantation for Nonalcoholic Liver Failure Ed Day, 1 David Best, 1 Ruth
More informationBiomarkers, alcohol and health: recognizing the switch from moderation to abuse
Biomarkers, alcohol and health: recognizing the switch from moderation to abuse Pamela Bean, Ph.D., M.B.A. Millennium Strategies, Madison, WI Rogers Memorial Hospital, Oconomowoc, WI Outline! The value
More informationPREDICTORS OF RELAPSE TO HARMFUL ALCOHOL AFTER ORTHOTOPIC LIVER TRANSPLANTATION
Alcohol & Alcoholism Vol. 41, No. 3, pp. 278 283, 2006 Advance Access publication 13 February 2006 doi:10.1093/alcalc/agh257 PREDICTORS OF RELAPSE TO HARMFUL ALCOHOL AFTER ORTHOTOPIC LIVER TRANSPLANTATION
More informationThe future s bright, the future s orange. the challenges of liver disease now and in the next 50 years
The future s bright, the future s orange. the challenges of liver disease now and in the next 50 years Peter Collins Consultant Hepatologist Bristol Royal Infirmary the challenges of liver disease now
More informationSubstance Abuse Treatment and Its Association With Relapse to Alcohol Use After Liver Transplantation
LIVER TRANSPLANTATION 19:1387 1395, 2013 ORIGINAL ARTICLE Substance Abuse Treatment and Its Association With Relapse to Alcohol Use After Liver Transplantation James R. Rodrigue, 1,2 Douglas W. Hanto,
More informationMEASUREMENT OF CARBOHYDRATE-DEFICIENT TRANSFERRED (CDT) IN A GENERAL MEDICAL CLINIC: IS THIS TEST USEFUL IN ASSESSING ALCOHOL CONSUMPTION?
Alcohol & Alcoholism Vol. 33, No. 3, pp. 304-309, 1998 MEASUREMENT OF CARBOHYDRATE-DEFICIENT TRANSFERRED (CDT) IN A GENERAL MEDICAL CLINIC: IS THIS TEST USEFUL IN ASSESSING ALCOHOL CONSUMPTION? GURUPRASAD
More informationDefinition and Diagnosis of Relapse to Drinking
Definition and Diagnosis of Relapse to Drinking T he issues of definition and diagnosis of relapse to drinking are somewhat intertwined because the methods for diagnosing relapse may differ depending on
More informationMonitoring Road Safety with Alcohol Biomarkers: Types, Measurement, Interpretation, and Recommendations 1
Monitoring Road Safety with Alcohol Biomarkers: Types, Measurement, Interpretation, and Recommendations 1 Paul R. Marques Pacific Institute for Research and Evaluation 11720 Beltsville Dr., Suite 900,
More informationWhat Is the Real Gain After Liver Transplantation?
LIVER TRANSPLANTATION 15:S1-S5, 9 AASLD/ILTS SYLLABUS What Is the Real Gain After Liver Transplantation? James Neuberger Organ Donation and Transplantation, NHS Blood and Transplant, Bristol, United Kingdom;
More informationEthyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Intensive Exposure to High Ethanol Content Mouthwash
Ethyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Intensive Exposure to High Ethanol Content Mouthwash Gary M. Reisfield 1, *, Bruce A. Goldberger 1,2, Amadeo J. Pesce 3, Bridgit O. Crews 3,
More informationOccupational exposure to alcohol-based hand sanitizers: the diriment role of alcohol biomarkers in hair
Occupational exposure to alcohol-based hand sanitizers: the diriment role of alcohol biomarkers in hair Submission by Bozzo Andrea mobile: +393401932599 e-mail: andrea2bozzo@gmail.com Introduction The
More informationA Review of SAMHSA s Revised Alcohol Biomarkers (EtG/EtS) Advisory - Spring By: Paul L. Cary Toxicology Laboratory University of Missouri
A Review of SAMHSA s Revised Alcohol Biomarkers (EtG/EtS) Advisory - Spring 2012 By: Paul L. Cary Toxicology Laboratory University of Missouri A bit of history: September 25, 2006, the U.S. Department
More informationHHS Public Access Author manuscript Alcohol Clin Exp Res. Author manuscript; available in PMC 2016 August 01.
The utility of commonly used laboratory tests to screen for excessive alcohol use in clinical practice Gina Gough, BA *,$$, Laura Heathers, BS *,$$, Deonna Puckett, BS *, Chi Westerhold, BS, Xiaowei Ren,
More informationETHYL GLUCURONIDE DETERMINATION IN HAIR AS AN INDICATOR OF CHRONIC ALCOHOL ABUSE: A FULLY VALIDATED METHOD BY GC-EI-MS/MS
FORENSICS AND TOXICOLOGY ANALYSIS ETHYL GLUCURONIDE DETERMINATION IN HAIR AS AN INDICATOR OF CHRONIC ALCOHOL ABUSE: A FULLY VALIDATED METHOD BY GC-EI-MS/MS Solutions for Your Analytical Business Markets
More informationAssessing and Treating Alcohol Relapse Risk in Liver Transplantation Candidates
Alcohol and Alcoholism Vol. 50, No. 2, pp. 164 172, 2015 Advance Access Publication 3 January 2015 doi: 10.1093/alcalc/agu096 Assessing and Treating Alcohol Relapse Risk in Liver Transplantation Candidates
More informationLiver Transplantation for Alcoholic Liver Disease: A Survey of Transplantation Programs in the United States
Liver Transplantation for Alcoholic Liver Disease: A Survey of Transplantation Programs in the United States James E. Everhart* and Thomas P. Beresford A lcoholic liver disease (ALD) is one of the most
More informationAmmonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis
Gastroenterology Report, 5(3), 2017, 232 236 doi: 10.1093/gastro/gow010 Advance Access Publication Date: 1 May 2016 Original article ORIGINAL ARTICLE Ammonia level at admission predicts in-hospital mortality
More informationBiological markers for abuse and addiction
Biological markers for abuse and addiction - Tomáš Zima Institute of Clinical Chemistry and Laboratory Diagnostic Charles University Denial is the feature of the alcoholism Patient s history. Family Psychologic
More informationCOMBINING THE AUDIT QUESTIONNAIRE AND BIOCHEMICAL MARKERS TO ASSESS ALCOHOL USE AND RISK OF ALCOHOL WITHDRAWAL IN MEDICAL INPATIENTS
Alcohol & Alcoholism Vol. 40, No. 6, pp. 515 519, 2005 Advance Access publication 15 August 2005 doi:10.1093/alcalc/agh189 COMBINING THE AUDIT QUESTIONNAIRE AND BIOCHEMICAL MARKERS TO ASSESS ALCOHOL USE
More informationAlcohol Biomarkers. BMF 77 - Alcohol Biomarkers
Alcohol Biomarkers BMF 77 - Alcohol Biomarkers Self-reporting of alcohol consumption is objective and inherently unreliable. This has led to an intensive search for a reliable marker of chronic, excessive
More informationAlcoholism and Alcohol Liver Disease from a Transplant Hepatology Perspective
Alcoholism and Alcohol Liver Disease from a Transplant Hepatology Perspective Clark Kulig, MD Director, Porter Center for Liver Care Denver, CO February 2015 Does quantity of alcohol correlate with liver
More informationORIGINAL INVESTIGATION. Screening for Alcohol Problems in Primary Care
Screening for Alcohol Problems in Primary Care A Systematic Review ORIGINAL INVESTIGATION David A. Fiellin, MD; M. Carrington Reid, PhD, MD; Patrick G. O Connor, MD, MPH Background: Primary care physicians
More informationAssociated Factors of CDT and GGT Sillanaukee et al. Dose Response of Laboratory Markers to Alcohol Consumption in a General Population
American Journal of Epidemiology Copyright 2 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 152, No. 8 Printed in U.S.A. Associated Factors of CDT and GGT
More informationACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries
ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries Ashwani K. Singal, MD, MS, FACG 1, Ramon Bataller, MD, PhD, FACG 2, Joseph Ahn, MD, MS, FACG (GRADE Methodologist) 3, Patrick S. Kamath,
More informationEvaluation and clinical application of ethyl glucuronide and ethyl sulfate as biomarkers for recent alcohol consumption
From the Department of Laboratory Medicine Division of Clinical Chemistry Karolinska Institutet Stockholm Sweden Evaluation and clinical application of ethyl glucuronide and ethyl sulfate as biomarkers
More informationAssessment of Alcohol Exposure: Testing for Ethylglucuronide (Etg), Ethylsulfate (Ets)
International Journal of Emergency Mental Health and Human Resilience, Vol. 19, No.3, pp. 1, ISSN 1522-4821 Assessment of Alcohol Exposure: Testing for Ethylglucuronide (Etg), Ethylsulfate (Ets) Abuelgasim
More informationALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH Vol. 39, No. 5 May 2015
ALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH Vol. 39, No. 5 May 2015 Determining Ethyl Glucuronide Cutoffs When Detecting Self-Reported Alcohol Use in Addiction Treatment Patients Jessica M. Lowe, Michael
More informationPREVALENCE OF NAFLD & NASH
- - PREVALENCE OF & USA Prevalence in Middle Age Patients San Antonio, Texas (Williams et al., Gastroenterology 2011; 140:124-31) Dallas Heart Study Prevalence Numbers (Browning et al., Hepatology 2004;40:1387-95)
More informationPaul Martin, MD, FACG. University of Miami. 30,000 deaths from cirrhosis per annum, alcohol implicated in 48%
Paul Martin, MD, FACG University of Miami 30,000 deaths from cirrhosis per annum, alcohol implicated in 48% Second commonest indication for liver transplant NIAA 2007 Page 1 of 26 Risk Factors Medical
More informationNON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) NON-ALCOHOLIC STEATOHEPATITIS (NASH) ADDRESSING A GROWING SILENT EPIDEMIC
NON-ALCOHOLIC FATTY LIVER DISEASE () & NON-ALCOHOLIC STEATOHEPATITIS () ADDRESSING A GROWING SILENT EPIDEMIC PREVALENCE OF / USA Prevalence in Middle Age Patients San Antonio, Texas (Williams et al., Gastroenterology
More informationEthyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Sustained Exposure to an Ethanol-Based Hand Sanitizer
Ethyl Glucuronide, Ethyl Sulfate, and Ethanol in Urine after Sustained Exposure to an Ethanol-Based Hand Sanitizer Gary M. Reisfield 1, *, Bruce A. Goldberger 1,2, Bridgit O. Crews 3, Amadeo J. Pesce 3,
More informationNON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) NON-ALCOHOLIC STEATOHEPATITIS (NASH) ADDRESSING A GROWING SILENT EPIDEMIC
NON-ALCOHOLIC FATTY LIVER DISEASE () & NON-ALCOHOLIC STEATOHEPATITIS () ADDRESSING A GROWING SILENT EPIDEMIC PREVALENCE OF / USA Prevalence in Middle Age Patients San Antonio, Texas (Williams et al., Gastroenterology
More informationRisk-Assessment Instruments for Pain Populations
Risk-Assessment Instruments for Pain Populations The Screener and Opioid Assessment for Patients with Pain (SOAPP) The SOAPP is a 14-item, self-report measure that is designed to assess the appropriateness
More informationALT and aspartate aminotransferase (AST) levels were measured using the α-ketoglutarate reaction (Roche,
Supplemental Methods Analytical determinations ALT and aspartate aminotransferase (AST) levels were measured using the α-ketoglutarate reaction (Roche, Basel, Switzerland). Glucose, triglyceride, total
More informationSupriya Sharma et al., Asian Journal of Pharmaceutical Technology & Innovation, 03 (14); 2015; Research Article
Asian Journal of Pharmaceutical Technology & Innovation ISSN: 2347-8810 Research Article Received on: 01-10-2015 Accepted on: 10-10-2015 Published on: 15-10-2015 Corresponding Author: * Dr. Supriya Sharma,
More informationThe role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis
The role of non-invasivemethods in evaluating liver fibrosis of patients with non-alcoholic steatohepatitis Objectives: Liver biopsy is the gold standard for diagnosing the extent of fibrosis in NAFLD/NASH;
More informationNIH Public Access Author Manuscript Alcohol Clin Exp Res. Author manuscript; available in PMC 2011 March 1.
NIH Public Access Author Manuscript Published in final edited form as: Alcohol Clin Exp Res. 2010 March 1; 34(3): 488 492. doi:10.1111/j.1530-0277.2009.01113.x. Phosphatidylethanol and Alcohol Consumption
More informationNIH Public Access Author Manuscript Traffic Inj Prev. Author manuscript; available in PMC 2012 April 1.
NIH Public Access Author Manuscript Published in final edited form as: Traffic Inj Prev. 2011 April ; 12(2): 136 141. doi:10.1080/15389588.2010.544048. Detection of phosphatidylethanol (PEth) in the blood
More informationA study of effect of alcohol on liver function tests (LFT) in Garhwal hills, India
International Journal of Research in Medical Sciences Gogoi JB et al. Int J Res Med Sci. 2018 Jan;6(1):94-98 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20175536
More informationCIRROSI E IPERTENSIONE PORTALE NELLA DONNA
Cagliari, 16 settembre 2017 CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Vincenza Calvaruso, MD, PhD Ricercatore di Gastroenterologia Gastroenterologia & Epatologia, Di.Bi.M.I.S. Università degli Studi di
More informationEthyl glucuronide in hair: is it a reliable marker of chronic high levels of alcohol consumption?
Miscellaneous Ethyl glucuronide in hair and alcohol consumption Lucia Politi et al. METHODS AND TECHNIQUES doi:10.1111/j.1360-0443.2006.01537.x Ethyl glucuronide in hair: is it a reliable marker of chronic
More informationFATTY LIVER DISEASE (NAFLD) (NASH) A GROWING
NON ALCOHOLIC FATTY LIVER DISEASE () & NON ALCOHOLIC S T E ATO H E PAT I T I S () ADDRESSING A GROWING SILENT EPIDEMIC Prevalence of & USA Prevalence in Middle Age Patients San Antonio, Texas (Williams
More informationAGE-RELATED CHANGES ON SERUM GGT ACTIVITY AND THE ASSESSMENT OF ETHANOL INTAKE
Alcohol & Alcoholism Vol. 41, No. 5, pp. 522 527, 2006 Advance Access publication 19 July 2006 doi:10.1093/alcalc/agl052 AGE-RELATED CHANGES ON SERUM GGT ACTIVITY AND THE ASSESSMENT OF ETHANOL INTAKE KATRI
More informationNCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease
NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease Hospital Number Admission to hospital 5. Trusts should ensure that medical patients are reviewed by a consultant
More informationInvestigation of HAZARDOUS DRINKING. 2 November 2010 best tests
Investigation of HAZARDOUS DRINKING 2 November 2010 best tests Key concepts: Approximately 20 25% of New Zealanders consume alcohol at a harmful or hazardous level In approximately three-quarters of patients
More informationORIGINAL ARTICLE. Eric F. Martin, 1 Jonathan Huang, 3 Qun Xiang, 2 John P. Klein, 2 Jasmohan Bajaj, 4 and Kia Saeian 1
LIVER TRANSPLANTATION 18:914 929, 2012 ORIGINAL ARTICLE Recipient Survival and Graft Survival are Not Diminished by Simultaneous Liver-Kidney Transplantation: An Analysis of the United Network for Organ
More informationLiver Transplantation: The End of the Road in Chronic Hepatitis C Infection
University of Massachusetts Medical School escholarship@umms UMass Center for Clinical and Translational Science Research Retreat 2012 UMass Center for Clinical and Translational Science Research Retreat
More informationLong-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance
Long-term Clinical Outcomes and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with HBsAg Seroclearance Gi-Ae Kim, Han Chu Lee *, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim,
More informationManagement of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy
Management of Ascites and Hepatorenal Syndrome Florence Wong University of Toronto June 4, 2016 6/16/2016 1 Disclosures Gore & Associates: Consultancy Sequana Medical: Research Funding Mallinckrodt Pharmaceutical:
More informationPrimary Care Validation of a Single-Question Alcohol Screening Test
JGIM ORIGINAL ARTICLES Primary Care Validation of a Single-Question Alcohol Screening Test Peter C. Smith, MD, MSc 1,5, Susan M. Schmidt 1, Donald Allensworth-Davies, MSc 2, and Richard Saitz, MD, MPH
More informationINTERNATIONAL JOURNAL OF ANATOMY PHYSIOLOGY AND BIOCHEMISTRY
ORIGINAL RESEARCH ARTICLE http://www.eternalpublication.com INTERNATIONAL JOURNAL OF ANATOMY PHYSIOLOGY AND BIOCHEMISTRY IJAPB: Volume: 4; Issue: 9; September 2017 ISSN(Online):2394-3440 Study on Diagnostic
More informationRelationship Between Blood Alcohol Concentration and Hepatic Enzymes in an Emergency Department
TZU CHI MED J March 2010 Vol 22 No 1 available at http://www.tzuchimedjnl.com/ Tzu Chi Medical Journal Original Article Relationship Between Blood Alcohol Concentration and Hepatic Enzymes in an Emergency
More informationLiver Transplantation Evaluation: Objectives
Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation
More informationRemoving Patients from the Liver Transplant Wait List: A Survey of US Liver Transplant Programs
LIVER TRANSPLANTATION 14:303-307, 2008 ORIGINAL ARTICLE Removing Patients from the Liver Transplant Wait List: A Survey of US Liver Transplant Programs Kevin P. Charpentier 1 and Arun Mavanur 2 1 Rhode
More informationThe clinical, radiographic, and/or histopathologic diagnosis. Utility of a New Model to Diagnose an Alcohol Basis for Steatohepatitis
GASTROENTEROLOGY 2006;131:1057 1063 Utility of a New Model to Diagnose an Alcohol Basis for Steatohepatitis WINSTON DUNN,* PAUL ANGULO,* SCHUYLER SANDERSON, LAITH H. JAMIL,* LINDA STADHEIM,* CHARLES ROSEN,
More informationAlcohol-Related Liver Disease
Alcohol-Related Liver Disease Nonalcoholic Fatty Liver Disease (NAFLD) 1 Why is the liver important? Your liver is a vital organ that performs many essential functions. It filters out harmful substances
More informationLiving donor liver transplantation for patients with alcoholic liver disease
Korean J Hepatobiliary Pancreat Surg 203;7:4-20 Original Article Living donor liver transplantation for patients with alcoholic liver disease Yo-Han Park, Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog
More informationReview Article. Ethyl glucuronide. Natalie E Walsham 1 and Roy A Sherwood 2
Review Article Ethyl glucuronide Natalie E Walsham 1 and Roy A Sherwood 2 1 Department of Clinical Biochemistry, University Hospital Lewisham, High Street, Lewisham, London SE13 6LH; 2 Department of Clinical
More informationKing Abdul-Aziz University Hospital (KAUH) is a tertiary
Modelling Factors Causing Mortality in Oesophageal Varices Patients in King Abdul Aziz University Hospital Sami Bahlas Abstract Objectives: The objective of this study is to reach a model defining factors
More informationHealthy Liver Cirrhosis
Gioacchino Angarano Clinica delle Malattie Infettive Università degli Studi di Foggia Healthy Liver Cirrhosis Storia naturale dell epatite HCVcorrelata in assenza di terapia Paestum 13-15 Maggio 24 The
More informationASSESSMENT AND DETECTION Detection Times for Urinary Ethyl Glucuronide and Ethyl Sulfate in Heavy Drinkers during Alcohol Detoxification
Alcohol & Alcoholism Vol. 44, No., pp. 55 6, 2009 Advance Access publication 29 October 2008 doi:.93/alcalc/agn084 ASSESSMENT AND DETECTION Detection Times for Urinary Ethyl Glucuronide and Ethyl Sulfate
More informationHepatitis C: Difficult-to-treat Patients 11th Paris Hepatology Conference 16th January 2018 Stefan Zeuzem, MD University Hospital, Frankfurt, Germany
Hepatitis C: Difficult-to-treat Patients 11th Paris Hepatology Conference 16th January 2018 Stefan Zeuzem, MD University Hospital, Frankfurt, Germany PHC 2018 - www.aphc.info Disclosures Advisory boards:
More informationInterpreting Liver Function Tests
PSH Clinical Guidelines Statement 2017 Interpreting Liver Function Tests Dr. Asad A Chaudhry Consultant Hepatologist, Chaudhry Hospital, Gujranwala, Pakistan. Liver function tests (LFTs) generally refer
More informationAccepted Manuscript. Letter to the Editor. Reply to: A cut-off serum creatinine value of 1.5 mg/dl for AKI - To be or not to be
Accepted Manuscript Letter to the Editor Reply to: A cut-off serum creatinine value of 1.5 mg/dl for AKI - To be or not to be Claudia Fagundes, Rogelio Barreto, Ezequiel Rodríguez, Isabel Graupera, Esteban
More informationBest Practices Review Drug & EtG/EtS Testing. By: Paul L. Cary Independent Forensic Toxicology Consultant
Best Practices Review Drug & EtG/EtS Testing By: Paul L. Cary Independent Forensic Toxicology Consultant Reasons for Drug Testing - WHY? act as a deterrent to future drug use identify participants who
More informationHepatitis C: Management of Previous Non-responders with First Line Protease Inhibitors
Hepatitis C: Management of Previous Non-responders with First Line Protease Inhibitors Fred Poordad, MD The Texas Liver Institute Clinical Professor of Medicine University of Texas Health Science Center
More informationAlcoholic Hepatitis: Management Options
Alcoholic Hepatitis: Management Options Paul J. Thuluvath, MD. FRCP Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore Professor of Surgery & Medicine, Georgetown University,
More informationThe Defined HHS/DOT Substituted Urine Criteria Validated Through a Controlled Hydration Study
The Defined HHS/DOT Substituted Urine Criteria Validated Through a Controlled Hydration Study Kenneth Edgell 1, Yale H. Caplan 2, Leon R. Glass 3, and Janine Denis Cook 4 1U.S. Department of Transportation,
More informationEVALUATION OF ABNORMAL LIVER TESTS
EVALUATION OF ABNORMAL LIVER TESTS MIA MANABAT DO PGY6 MOA 119 TH ANNUAL SPRING SCIENTIFIC CONVENTION MAY 19, 2018 EVALUATION OF ABNORMAL LIVER TESTS Review of liver enzymes vs liver function tests Clinical
More informationFederal agency says urine-alcohol test isn't totally reliable
Federal agency says urine-alcohol test isn't totally reliable Thursday, October 05, 2006 By Kevin Helliker, The Wall Street Journal [INFORMATION PROVIDED BY POST- GAZETTE.COM] A widely used method of detecting
More informationHow and why to measure renal function in patients with liver disease?
ow and why to measure renal function in patients with liver disease? P. Angeli, Dept. of Medicine, Unit of Internal Medicine and epatology (), University of Padova (Italy) pangeli@unipd.it 10th Paris epatology
More informationPredictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
More informationPOST TRANSPLANT OUTCOMES IN PSC
POST TRANSPLANT OUTCOMES IN PSC Kidist K. Yimam, MD Medical Director, Autoimmune Liver Disease Program Division of Hepatology and Liver Transplantation California Pacific Medical Center (CPMC) PSC Partners
More informationThe 15-method: training primary care practitioners in treatment of alcohol dependence
The 15-method: training primary care practitioners in treatment of alcohol dependence Simple but effective tools for treating alcohol dependence Reluctance to ask about alcohol is largely due to not knowing
More informationDeclaration of Conflict of Interest. No potential conflict of interest to disclose with regard to the topics of this presentations.
Declaration of Conflict of Interest No potential conflict of interest to disclose with regard to the topics of this presentations. Clinical implications of smoking relapse after acute ischemic stroke Furio
More informationLong-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: Impact of structured management on recidivism
Scandinavian Journal of Gastroenterology, 2005; 40: 206 /216 ORIGINAL ARTICLE Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: Impact of structured management
More informationGeographic Differences in Event Rates by Model for End-Stage Liver Disease Score
American Journal of Transplantation 2006; 6: 2470 2475 Blackwell Munksgaard C 2006 The Authors Journal compilation C 2006 The American Society of Transplantation and the American Society of Transplant
More informationAlbumin-to-bilirubin score for assessing the in-hospital death in cirrhosis
Original Article Albumin-to-bilirubin score for assessing the in-hospital death in cirrhosis Lichun Shao 1 *, Bing Han 1 *, Shu An 2, Jiaxin Ma 1, Xiaozhong Guo 3, Fernando Gomes Romeiro 4, Andrea Mancuso
More informationABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust
ABNORMAL LIVER FUNCTION TESTS Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust INTRODUCTION Liver function tests Cases Non invasive fibrosis measurement Questions UK MORTALITY RATE
More information6 Riunione Monotematica A.I.S.F NASH malattia epatica, oncologica e cardiovascolare
6 Riunione Monotematica A.I.S.F. 2015 NASH malattia epatica, oncologica e cardiovascolare Modena, 9 ottobre 2015 Massimo Colombo NAFLD e HCC: caratteristiche distintive Chairman Department of Liver, Kidney,
More informationRole of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation
BRIEF REPORT Role of Hepatitis B Virus Genotypes in Chronic Hepatitis B Exacerbation Man-Fung Yuen, 1 Erwin Sablon, 2 Danny Ka-Ho Wong, 1 He-Jun Yuan, 1 Benjamin Chun-Yu Wong, 1 Annie On-On Chan, 1 and
More information1 pint beer = 2 units 1 glass sherry = 1 unit 1 glass wine = 1 unit (one 750ml bottle = 7-10 units) 1 bottle of 30 units
Alcohol Abuse: Acute vs. : An overview Dr Carolyn Fedler Of all the drugs of abuse (DOA) category, alcohol is the most commonly abused. Alcohol abuse is a serious health issue with major socio-economic
More informationEarly Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment
American Journal of Transplantation 2016; 16: 850 859 Wiley Periodicals Inc. Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons doi: 10.1111/ajt.13527
More informationDonor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation
8 Original Article Donor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation Neema Kaseje 1 Samuel Lüthold 2 Gilles Mentha 3 Christian Toso 3 Dominique Belli 2 Valérie McLin 2 Barbara
More information9/22/2015. Timothy W. Lineberry, MD Chief Medical Officer Greater Green Bay Aurora Health Care
Timothy W. Lineberry, MD Chief Medical Officer Greater Green Bay Aurora Health Care Differentiate between hazardous drinking and alcohol use disorders Recognize issues associated with comorbidity between
More informationImproved Hepatic Fibrosis Grading Using Point Shear Wave Elastography and Machine Learning
Improved Hepatic Fibrosis Grading Using Point Shear Wave Elastography and Machine Learning Presenter: Hersh Sagreiya 1, M.D. Authors: Alireza Akhbardeh 1, Ph.D., Isabelle Durot 1, M.D., Carlo Filice 2,
More informationSteatosi epatica ed HCV
Steatosi epatica ed HCV Malattie delle vie biliari ed Epatologia Rho, Auditorium Padri Oblati, 11 Novembre 2006 Piero L. Almasio Università di Palermo HISTOPATHOLOGY Steatosis and accelerated fibrogenesis:
More informationBiomarkers for Underreported Alcohol Use
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/biomarkers-for-underreported-alcohol-use/3891/
More informationScience of Drinking: Alcohol Use, Abuse and Alcohol Biomarkers Session # 2000
Science of Drinking: Alcohol Use, Abuse and Alcohol Biomarkers Session # 2000 Amitava Dasgupta, Ph.D Professor of Pathology and Laboratory Medicine University of Texas Medical School at Houston Disclosure
More information